Literature DB >> 17702639

Innate immune evasion by hepatitis C virus and West Nile virus.

Brian C Keller1, Cynthia L Johnson, Andrea Kaup Erickson, Michael Gale.   

Abstract

Antiviral immunity in mammals involves several levels of surveillance and effector actions by host factors to detect viral pathogens, trigger alpha/beta interferon production, and to mediate innate defenses within infected cells. Our studies have focused on understanding how these processes are regulated during infection by hepatitis C virus (HCV) and West Nile virus (WNV). Both viruses are members of the Flaviviridae and are human pathogens, but they each mediate a very different disease and course of infection. Our results demonstrate common and unique innate immune interactions of each virus that govern antiviral immunity and demonstrate the central role of alpha/beta interferon immune defenses in controlling the outcome of infection.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17702639      PMCID: PMC2757293          DOI: 10.1016/j.cytogfr.2007.06.006

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  62 in total

1.  Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.

Authors:  Eileen Foy; Kui Li; Chunfu Wang; Rhea Sumpter; Masanori Ikeda; Stanley M Lemon; Michael Gale
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

2.  Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.

Authors:  Haizhen Zhu; Hongshan Zhao; Christin D Collins; Sarah E Eckenrode; Qingguo Run; Richard A McIndoe; James M Crawford; David R Nelson; Jin-Xiong She; Chen Liu
Journal:  Hepatology       Date:  2003-05       Impact factor: 17.425

3.  Expression analysis and genomic characterization of human melanoma differentiation associated gene-5, mda-5: a novel type I interferon-responsive apoptosis-inducing gene.

Authors:  Dong-Chul Kang; Rahul V Gopalkrishnan; Lin Lin; Aaron Randolph; Kristoffer Valerie; Sidney Pestka; Paul B Fisher
Journal:  Oncogene       Date:  2004-03-04       Impact factor: 9.867

4.  Genomic analysis of the host response to hepatitis C virus infection.

Authors:  Andrew I Su; John P Pezacki; Lisa Wodicka; Amy D Brideau; Lubica Supekova; Robert Thimme; Stefan Wieland; Jens Bukh; Robert H Purcell; Peter G Schultz; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-19       Impact factor: 11.205

5.  The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses.

Authors:  Mitsutoshi Yoneyama; Mika Kikuchi; Takashi Natsukawa; Noriaki Shinobu; Tadaatsu Imaizumi; Makoto Miyagishi; Kazunari Taira; Shizuo Akira; Takashi Fujita
Journal:  Nat Immunol       Date:  2004-06-20       Impact factor: 25.606

6.  The host response to West Nile Virus infection limits viral spread through the activation of the interferon regulatory factor 3 pathway.

Authors:  Brenda L Fredericksen; Maria Smith; Michael G Katze; Pei-Yong Shi; Michael Gale
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  Effect of interferon-alpha and interferon-inducers on West Nile virus in mouse and hamster animal models.

Authors:  John D Morrey; Craig W Day; Justin G Julander; Lawrence M Blatt; Donald F Smee; Robert W Sidwell
Journal:  Antivir Chem Chemother       Date:  2004-03

8.  Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.

Authors:  Maria W Smith; Zhaoxia N Yue; Marcus J Korth; Hao A Do; Loreto Boix; Nelson Fausto; Jordi Bruix; Robert L Carithers; Michael G Katze
Journal:  Hepatology       Date:  2003-12       Impact factor: 17.425

9.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

Review 10.  West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas.

Authors:  H G Zeller; I Schuffenecker
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 5.103

View more
  13 in total

1.  Inhibitor of κB kinase epsilon (IKK(epsilon)), STAT1, and IFIT2 proteins define novel innate immune effector pathway against West Nile virus infection.

Authors:  Olivia Perwitasari; Hyelim Cho; Michael S Diamond; Michael Gale
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

2.  Dengue virus subverts the interferon induction pathway via NS2B/3 protease-IκB kinase epsilon interaction.

Authors:  Yesseinia I Angleró-Rodríguez; Petraleigh Pantoja; Carlos A Sariol
Journal:  Clin Vaccine Immunol       Date:  2013-10-30

3.  The SCHOOL of nature: IV. Learning from viruses.

Authors:  Alexander B Sigalov
Journal:  Self Nonself       Date:  2010-10

4.  Therapy with TLR7 agonists induces lymphopenia: correlating pharmacology to mechanism in a mouse model.

Authors:  Hannah Perkins; Tansi Khodai; Houria Mechiche; Peter Colman; Frances Burden; Carl Laxton; Nigel Horscroft; Tom Corey; Deborah Rodrigues; Jaiessh Rawal; Jonathan Heyen; Mark Fidock; Mike Westby; Helen Bright
Journal:  J Clin Immunol       Date:  2012-04-05       Impact factor: 8.317

5.  Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection.

Authors:  Marija Zeremski; Giles Hooker; Marla A Shu; Emily Winkelstein; Queenie Brown; Don C Des Jarlais; Leslie H Tobler; Barbara Rehermann; Michael P Busch; Brian R Edlin; Andrew H Talal
Journal:  J Hepatol       Date:  2011-01-21       Impact factor: 25.083

6.  Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles.

Authors:  Anna K Overby; Vsevolod L Popov; Matthias Niedrig; Friedemann Weber
Journal:  J Virol       Date:  2010-06-16       Impact factor: 5.103

7.  Natural history of HCV infection.

Authors:  Shiv K Sarin; Manoj Kumar
Journal:  Hepatol Int       Date:  2012-03-09       Impact factor: 6.047

8.  West nile virus: characteristics of an african virus adapting to the third millennium world.

Authors:  Marina Monini; Emiliana Falcone; Luca Busani; Roberto Romi; Franco Maria Ruggeri
Journal:  Open Virol J       Date:  2010-04-22

9.  Mannan-binding lectin MBL2 gene polymorphism in chronic hepatitis C: association with the severity of liver fibrosis and response to interferon therapy.

Authors:  M L Alves Pedroso; A B W Boldt; L Pereira-Ferrari; R Steffensen; E Strauss; J C Jensenius; S O Ioshii; I Messias-Reason
Journal:  Clin Exp Immunol       Date:  2008-03-10       Impact factor: 4.330

Review 10.  Towards a small animal model for hepatitis C.

Authors:  Alexander Ploss; Charles M Rice
Journal:  EMBO Rep       Date:  2009-10-16       Impact factor: 8.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.